Efficacy and safety of Levofloxacin, Clarithromycin and Esomeprazol as first line triple therapy for Helicobacter pylori eradication in Middle East. Prospective, randomized, blind, comparative, multicenter study (Q42984853)
Jump to navigation
Jump to search
scientific article published on 16 June 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of Levofloxacin, Clarithromycin and Esomeprazol as first line triple therapy for Helicobacter pylori eradication in Middle East. Prospective, randomized, blind, comparative, multicenter study |
scientific article published on 16 June 2010 |
Statements
1 reference
Efficacy and safety of Levofloxacin, Clarithromycin and Esomeprazol as first line triple therapy for Helicobacter pylori eradication in Middle East. Prospective, randomized, blind, comparative, multicenter study (English)
1 reference
M Assem
1 reference
G El Azab
1 reference
M Abdel Rasheed
1 reference
M Abdelfatah
1 reference
M Shastery
1 reference
16 June 2010
1 reference
1 reference
Identifiers
1 reference